Current Trends in Targeted Therapy for Drug-Resistant Infections

Current Trends in Targeted Therapy for Drug-Resistant Infections Publisher Pubmed

Rahbarnia L¹ ; Farajnia S² ; Naghili B¹ ; Ahmadzadeh V² ; Veisi K^{3, 4} ; Baghban R⁵ ; Toraby S⁶

Source: Applied Microbiology and Biotechnology Published:2019

Abstract

Escalating antibiotic resistance is now a serious menace to global public health. It may be led to the emergence of “postantibiotic age” in which most of infections are untreatable. At present, there is an essential need to explore novel therapeutic strategies as a strong and sustainable pipeline to combat antibiotic-resistant infections. This review focuses on recent advances in this area including therapeutic antibodies, antimicrobial peptides, vaccines, gene therapy, genome editing, and phage therapy for tackling drug-resistant infections. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature.

Related Docs

View other Related Docs

1. From Cure to Crisis: Understanding the Evolution of Antibiotic-Resistant Bacteria in Human Microbiota, Biomolecules (2025)

2. Beyond Antibiotics: Exploring Multifaceted Approaches to Combat Bacterial Resistance in the Modern Era: A Comprehensive Review, Frontiers in Cellular and Infection Microbiology (2025)

3. Treatment Options for Infections Caused by Multidrug-Resistant Gram-Negative Bacteria: A Guide to Good Clinical Practice, Future Microbiology (2023)

Experts (# of related papers)

View all Related Experts

Mohammadreza Salehi (2)

Alireza Partoazar (1)

Style	Citing Format
MLA	Rahbarnia L, et al.. "Current Trends in Targeted Therapy for Drug-Resistant Infections." Applied Microbiology and Biotechnology, vol. 103, no. 20, 2019, pp. 8301-8314.
APA	Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S (2019). Current Trends in Targeted Therapy for Drug-Resistant Infections. Applied Microbiology and Biotechnology, 103(20), 8301-8314.
Chicago	Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S. "Current Trends in Targeted Therapy for Drug-Resistant Infections." Applied Microbiology and Biotechnology 103, no. 20 (2019): 8301-8314.
Harvard	Rahbarnia L et al. (2019) 'Current Trends in Targeted Therapy for Drug-Resistant Infections', Applied Microbiology and Biotechnology, 103(20), pp. 8301-8314.
Vancouver	Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, et al.. Current Trends in Targeted Therapy for Drug-Resistant Infections. Applied Microbiology and Biotechnology. 2019;103(20):8301-8314.
BibTex	@article{ author = {Rahbarnia L and Farajnia S and Naghili B and Ahmadzadeh V and Veisi K and Baghban R and Toraby S}, title = {Current Trends in Targeted Therapy for Drug-Resistant Infections}, journal = {Applied Microbiology and Biotechnology}, volume = {103}, number = {20}, pages = {8301-8314}, year = {2019} }
RIS	TY - JOUR AU - Rahbarnia L AU - Farajnia S AU - Naghili B AU - Ahmadzadeh V AU - Veisi K AU - Baghban R AU - Toraby S TI - Current Trends in Targeted Therapy for Drug-Resistant Infections JO - Applied Microbiology and Biotechnology VL - 103 IS - 20 SP - 8301 EP - 8314 PY - 2019 ER -

Science Communicator Platform

Authors

Abstract